Učitavanje...
Detectable Prostate-Specific Antigen Nadir During Androgen-Deprivation Therapy Predicts Adverse Prostate Cancer Specific Outcomes: Results from the SEARCH Database
BACKGROUND: A prostate-specific antigen (PSA) level <0.2 ng/ml on androgen-deprivation therapy (ADT) is correlated with better outcomes. However, not all men reach a nadir PSA level within 8 mo. Whether the lowest PSA on ADT—specifically, <0.2 ng/ml—can be used for risk stratification is untes...
Spremljeno u:
| Glavni autori: | , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2012
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3634863/ https://ncbi.nlm.nih.gov/pubmed/23245686 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2012.11.052 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|